Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome

van Geffen, Johanna P.; Swieringa, Frauke; van Kuijk, Kim; Tullemans, Bibian M. E.; Solari, Fiorella A.; Peng, Bing; Clemetson, Kenneth J.; Farndale, Richard W.; Dubois, Ludwig J.; Sickmann, Albert; Zahedi, René P.; Ahrends, Robert; Biessen, Erik A. L.; Sluimer, Judith C.; Heemskerk, Johan W. M.; Kuijpers, Marijke J. E.

doi:10.1038/s41598-020-78522-9

Download PDF

Article
Open access
Published: 08 December 2020

Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome

Johanna P. van Geffen¹,
Frauke Swieringa^1,2,
Kim van Kuijk³,
Bibian M. E. Tullemans¹,
Fiorella A. Solari²,
Bing Peng²,
Kenneth J. Clemetson⁴,
Richard W. Farndale⁵,
Ludwig J. Dubois⁶,
Albert Sickmann²,
René P. Zahedi^2,7,
Robert Ahrends^2,8,
Erik A. L. Biessen^3,9,
Judith C. Sluimer^3,10,
Johan W. M. Heemskerk¹ &
…
Marijke J. E. Kuijpers¹

Scientific Reports volume 10, Article number: 21407 (2020) Cite this article

2097 Accesses
13 Citations
1 Altmetric
Metrics details

Subjects

Abstract

Hyperlipidemia is a well-established risk factor for cardiovascular diseases. Millions of people worldwide display mildly elevated levels of plasma lipids and cholesterol linked to diet and life-style. While the prothrombotic risk of severe hyperlipidemia has been established, the effects of moderate hyperlipidemia are less clear. Here, we studied platelet activation and arterial thrombus formation in Apoe^−/− and Ldlr^−/− mice fed a normal chow diet, resulting in mildly increased plasma cholesterol. In blood from both knockout mice, collagen-dependent thrombus and fibrin formation under flow were enhanced. These effects did not increase in severe hyperlipidemic blood from aged mice and upon feeding a high-fat diet (Apoe^−/− mice). Bone marrow from wild-type or Ldlr^−/− mice was transplanted into irradiated Ldlr^−/− recipients. Markedly, thrombus formation was enhanced in blood from chimeric mice, suggesting that the hyperlipidemic environment altered the wild-type platelets, rather than the genetic modification. The platelet proteome revealed high similarity between the three genotypes, without clear indication for a common protein-based gain-of-function. The platelet lipidome revealed an altered lipid profile in mildly hyperlipidemic mice. In conclusion, in Apoe^−/− and Ldlr^−/− mice, modest elevation in plasma and platelet cholesterol increased platelet responsiveness in thrombus formation and ensuing fibrin formation, resulting in a prothrombotic phenotype.

Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation

Article Open access 12 December 2022

Carina Mauersberger, Hendrik B. Sager, … Thorsten Kessler

Analysis of platelets from a diet-induced obesity rat model: elucidating platelet dysfunction in obesity

Article Open access 04 August 2020

María N. Barrachina, Luis A. Morán, … Ángel García

Alkaline ceramidase 1–mediated platelet ceramide catabolism mitigates vascular inflammation and abdominal aortic aneurysm formation

Article 16 November 2023

Xu Zhang, Ze Gong, … Wei Kong

Introduction

Hyperlipidemia initiates, drives and aggravates atherosclerotic plaque formation, as an underlying cause for cardiovascular diseases^1,2. In human adults, low plasma levels of cholesterol and triglycerides are highly desirable^3,4. In 2015 however, 95 million adult Americans were presenting with elevated levels (> 200 mg/dl) of total cholesterol⁵. Similarly, in Europe the high prevalence of high plasma cholesterol is a serious health problem⁶. The relationship between hyperlipidemia, atherosclerosis and thrombosis has been extensively investigated^7,8. Already in 1975, it was suggested that hypercholesterolemia in monkeys predisposes to increased platelet aggregation⁹. However, the majority of the studies investigating the effects of hyperlipidemia on atherothrombosis were performed in genetically modified mice, fed a high fat diet¹⁰. Depending on the genotype—Apoe^−/− or Ldlr^−/−—feeding with a high fat diet causes plasma cholesterol and triglycerides levels increase to levels at least 5–tenfold higher than observed in hyperlipidemic individuals (> > 240 mg/dL)^11,12. These levels are well known to induce plaque formation with ensuing atherothrombotic effects. However, much less is known about the effects of less aggressive forms of hyperlipidemia, that align with those seen in humans (mildly increased cholesterol levels of 200–239 mg/dL), on the thrombosis propensity and platelet activation.

Next to absolute cholesterol levels, also lipoprotein profiles of mice are distinct from man, in whom cholesterol is transported by low-density lipoproteins¹². The Apoe^−/− mice carry plasma cholesterol in majority as very low-density lipoproteins and chylomicrons. The lipoprotein profile of Ldlr^−/− mice resembles more that of human hypercholesterolemia, with cholesterol preferentially transported by low-density lipoproteins^12,13. Both knockouts develop progressive atherosclerosis of the aortic arch and carotid arteries, although the precise mechanism differs between the genotypes^{10,14,15,16,17}, in that atherosclerotic lesion formation upon LDLR deficiency more relies on the dietary fat content¹¹.

In the present study, we aimed to investigate how a moderate elevation of the plasma cholesterol influences platelet activation and thrombus formation. For this purpose, we adapted two multiparameter ex vivo methods of shear-dependent whole blood thrombus formation for murine blood, to study (1) platelet activation and aggregation at a collagen surface and (2) the kinetics of collagen/tissue factor (TF)-induced thrombus and fibrin clot formation. The mice were fed a normal chow diet, in order to provoke mildly increased plasma cholesterol levels in Apoe^−/− and Ldlr^−/− mice. We detected a platelet-dependent increase in thrombotic tendency using blood from both Apoe^−/− and Ldlr^−/− mice, compared with normocholesterolemic wild-type mice. These effects were not further aggravated in aged mice, nor in high-fat diet fed Apoe^−/− mice with 50% higher plasma cholesterol levels. Exploration of the platelet proteome and lipidome revealed additional insight into the platelet factors contributing to this prothrombotic phenotype of platelets.

Results

Multi-parameter assessment of platelet prothrombotic phenotype under flow in Ldlr^−/− and Apoe^−/− mice

To investigate how platelet functions are modified under mildly hyperlipidemic conditions in both Apoe^−/− or Ldlr^−/− mice^16,18, we adapted a previously validated multiparameter test for the simultaneous assessment of platelet adhesion and activation in human blood¹⁹. Accordingly, using microfluidics, recalcified whole blood from wild-type, Apoe^−/− and Ldlr^−/− mice of 9–12 weeks old, held on normal chow diet, was perfused over collagen micro-spots. Analysis of the platelet deposition on collagen did not show differences in adhesion between the genotypes (Fig. 1A,Bi). However, the thrombi that were generated with blood from Apoe^−/− or Ldlr^−/− mice appeared denser in structure and more layered compared to the wild-type mice (Fig. 1A). The difference was also seen as an increased thrombus contraction and aggregate multilayer score (Fig. 1C, see P3 and P4). In addition, specific platelet activation markers (PS exposure, P-selectin expression and integrin α_IIbβ₃ activation) were increased for the Ldlr^−/− mice, compared to wild-types (Fig. 1B). However, for Apoe^−/− mice, PS exposure remained unchanged, and other activation markers were slightly reduced (Fig. 1Bi).

To investigate whether the thrombus-forming process was influenced by the (lipid) composition of the blood, blood samples were analyzed from both young and aged wild-type, Apoe^−/− and Ldlr^−/− mice. Overall, similar genotype-induced differences were observed for platelet adhesion and activation parameters for the aged animals as compared to the young mice (Fig. 1Bii, suppl. Figure 1A). Hematological parameters indicated a 35% lower platelet count in blood from all Ldlr^−/− mice, but not Apoe^−/− mice, compared to wild-types (Suppl. Table 1). Across mouse strains, platelet count increased by 25–45% upon ageing, in agreement with published findings²⁰. Red and white blood cell counts were similar between genotypes and age groups. It has been reported that Apoe^−/− mice develop leukocytosis, especially when receiving a high-fat diet¹¹. In our study with mice on normal chow diet, numbers of leukocytes were similar in all genotypes (Suppl. Table 1). However, in Apoe^−/− mice that were held on high-fat diet (Suppl. Figure 2), we noted a significant increase in leukocyte counts from 3.8 ± 0.8 × 10³/µl to 6.1 ± 2.4 × 10³/µl (mean ± SD, n = 10–12, P < 0.01). In comparison to wild-type mice, plasma cholesterol levels were more elevated in aged Apoe^−/− mice (sixfold) than in aged Ldlr^−/− mice (threefold) (Suppl. Table 1).

A heatmap was generated for a more systematic analysis of the eight thrombus parameters, which were averaged and scaled per parameter (Suppl. Figure 1B). Statistical analysis indicated that only 1 out of 8 parameters differed between the age groups of Ldlr^−/− mice, and that none of the parameters differed between the young and old Apoe^−/− mice. This allowed us to pool the values from either age group per genotype (Fig. 1C). The effect-size differential heatmap of Fig. 1D, obtained by filtering differences from wild-types against significance (P < 0.05), then pointed to a clear prothrombotic phenotype of the blood from both knockout mice, albeit with a different pattern of increased parameters. The Apoe^−/− mice showed predominantly increased platelet aggregation parameters (morphological score, multilayer score and platelet aggregate coverage) (Fig. 1D); while the Ldlr^−/− mice showed elevated platelet aggregation as well as activation markers (PS exposure, P-selectin expression and integrin activation).

Flow cytometry analysis with isolated platelets confirmed that platelet activation was increased upon GPVI stimulation, when comparing the knockouts with wild-types (Fig. 1E). In an additional study, Apoe^−/− mice were fed a high fat diet, increasing plasma cholesterol by 50% (Suppl. Figure 2A). Markedly, this diet did not further increase the prothrombotic phenotype upon ApoE deficiency, as detected by either microfluidics tests or flow cytometry of platelet activation with a panel of agonists (Suppl. Figure 2B,C). Given that flow perfusion over collagen is a relevant surface for identifying changes in murine arterial thrombosis^21,22, we concluded that the platelets from both Apoe^−/− and Ldlr^−/− mice carry a prothrombotic phenotype, with Apoe^−/− platelets showing predominantly an increased aggregation tendency and Ldlr^−/− platelets showing an increased secretion.

Enhanced platelet-dependent fibrin and thrombus formation under flow in Ldlr^−/− and Apoe^−/− mice

To investigate whether the increased platelet responses of Apoe^−/− and Ldlr^−/− mice extended to coagulation stimulation, i.e. fibrin formation, we adapted a method to assess the kinetics of this process using perfused human blood²³. Therefore, recalcified mouse blood was labeled with DiOC₆ and AF647-fibrinogen, and perfused through a flow chamber over two microspots consisting of collagen type I (upstream microspot Ma) and collagen type I + TF (downstream microspot Mb).

Whole blood flow under coagulating conditions resulted in similar platelet deposition for all three genotypes on collagen/TF (Fig. 2A,Bi), although a slight but significant decrease in platelet deposition was observed for aged Ldlr^−/− mice compared to the corresponding wild-types (Fig. 2Bii). Using blood from young or aged wild-type mice, the co-coating of TF significantly enhanced platelet deposition on collagen (Fig. 2B vs. Suppl. Figure 4B, P < 0.001). With blood from Apoe^−/− or Ldlr^−/− mice, platelet deposition in the absence of TF was enhanced after 4–6 min, when compared to wild-types (Suppl. Figure 4A, D), while TF did not further enhance this parameter (Fig. 2B). Accordingly, in contrast to wild-type blood, there was measurable fibrin formation in the absence of TF with blood from Apoe^−/− or Ldlr^−/− mice (Fig. 2B, Suppl. Figure 4C). At the TF-containing spot Mb, 2–3 times more fibrin was formed when using blood from Apoe^−/− or Ldlr^−/− mice than with wild-type blood (Fig. 2A,B). In agreement with this, the time to fibrin formation was shortened in blood from either knockout mouse (Fig. 2B). Of note, in the absence of TF, no fibrin was formed in wild-type mice within 10 min, while in all young and aged knockout mice fibrin was generated within 10 min (Fig. 2B). No differences were recorded between young or old mice, regardless of the genotype (Fig. 2, Suppl. Figures 3 and 4). Kinetic analysis of platelet deposition in the presence of TF did not reveal differences between genotypes or age groups, while fibrin deposition in time was markedly enhanced for both Apoe^−/− and Ldlr^−/− mice compared to wild-type mice (Suppl. Figure 3B). To determine the rate of fibrin formation, the slope of each curve was calculated over the steepest part (1.5–3.75 min). For wild-type blood, the maximum slope was 4.8%SAC/min. For Apoe^−/− blood, this slope increased to 8.5%SAC/min (P < 0.05 vs. wild-type). For Ldlr^−/− mice this value further elevated to 13.4%SAC/min (P < 0.0005 vs. wild-type).

To allow a direct comparison of all differences in thrombus formation, a heatmap was generated using five outcome parameters (Pa-e), four of which were assessed at 0, 2, 4 and 6 min (Suppl. Figure 3C). Of the 34 obtained parameters of thrombus formation on two microspots, only 2–8 parameters showed significant differences between the mouse age groups of all genotypes (Suppl. Figure 3C). In agreement with previous data²⁴, the various parameters per microspot were mostly correlated when examined per genotype (Fig. 2C). When comparing the knockout strains, gain-of-function values (represented as yellow–red coloring) were observed for both the Apoe^−/− and Ldlr^−/− mice, when compared to corresponding wild-types, especially for the fibrin parameters Pc, Pd and Pe.

A subtraction heatmap was created for better visualize of differences in terms of effect sizes per parameter (Fig. 2D). This revealed a similar prothrombotic phenotype in phosphatidylserine exposure and fibrin formation for both Apoe^−/− and Ldlr^−/− mice, especially in the presence of TF. This extended analysis hence suggested that the hyperlipidemic condition in either knockout strain led to an increase in platelet activation and ensuing fibrin formation under flow conditions.

To investigate if coagulation processes were altered, platelet-free plasma from the genotypes was analyzed for the presence of thrombin-anti-thrombin (TAT) complexes, as a sensitive marker of ongoing thrombin generation in vivo²⁵. No significant differences between the three strains were seen (Fig. 3A). The TF-induced thrombin generation test in plasma showed a slightly increased endogenous thrombin potential for Apoe^−/−, compared to wild-type or Ldlr^−/− plasma (Fig. 3B). This pointed to a weak enhancement of coagulant activity in only Apoe^−/− mice, which however cannot fully explain the increased platelet-dependent fibrin formation during perfusion of whole blood from both Apoe^−/− and Ldlr^−/− mice.

When relating per genotype the plasma cholesterol levels (Suppl. Table 1) with the extent of PS exposure in isolated platelets (Fig. 1E), there appeared to be a good correlation (Fig. 4A). Furthermore, this correlation extended to the amounts of fibrin formed (Fig. 4B). Although correlational, this analysis suggested a role of plasma cholesterol in the mildly hyperlipidemic mice in determining platelet-dependent coagulation.

Hyperlipidemic environment promotes gain-of-platelet-function

To provide more direct evidence for the influence of plasma cholesterol on platelets in these mice, we then performed a transplantation study. Bone marrow obtained from either wild-type or Ldlr^−/− donor mice was injected into whole-body irradiated Ldlr^−/− recipient mice, and the mouse blood samples were analyzed at 6 weeks after transplantation. Repopulation of the bone marrow with transplanted cells was confirmed in DNA extracted from white blood cells (92 ± 2% LDLR chimerism). In addition, plasma cholesterol levels were checked, and appeared to be equally high in both groups (Suppl. Table 2). Flow cytometry analysis of the blood samples demonstrated a similar, high platelet activation tendency of the WT^BM and Ldlr^−/−BM platelets (Fig. 5A). Flow perfusion experiments on collagen I indicated a similar gain-of-platelet-function for both transplantation arms, i.e. similar to the blood from full Ldlr^−/−mice, when compared to wild-type blood (Fig. 5B). This provided a clear indication that the hyperlipidemic environment in the recipient Ldlr^−/− mice provoked a gain-of-platelet function of wild-type platelets, to reach the prothrombic activity of Ldlr^−/− platelets.

Minor common changes in proteome of platelets from Ldlr^−/− and Apoe^−/− mice

Using quantitative proteomics analysis, we explored the protein composition of Apoe^−/− and Ldlr^−/− platelets in comparison to wild-type platelets. From platelet samples of all genotypes, ratio information was obtained regarding 1,533 unique proteins. Volcano plots indicated differences in ratios for multiple identified proteins between wild-type and Apoe^−/− or Ldlr^−/− platelets (Fig. 6A). Statistics after correction for multiple testing pointed to 655 and 21 significant protein changes in the Apoe^−/− and Ldlr^−/− platelets, respectively. Of these proteins, only a few showed relevant changes, i.e. > 1.5-fold as previously defined^26,27. For Apoe^−/− platelets this concerned 277 proteins (18%), and for Ldlr^−/− platelet 9 proteins (0.6%) (Fig. 6B and Suppl. Table 3). Remarkably, only 4 proteins were jointly upregulated and none were jointly downregulated in both knockout strains (Suppl. Table 3C).

Regarding cellular functions of the altered proteins^28,29, these were confined to mostly structural proteins (Table 1). For Apoe^−/− mice downregulation was observed in several mitochondrial and metabolic proteins, while both up- and downregulation was seen of in particular reticular, membrane and signaling-related proteins. Specifically, in Ldlr^−/− platelets, secretory proteins were upregulated compared to wild-type platelets. However, close inspection of the (moderately) altered proteins did not reveal candidates for a common increase in platelet activation tendency for the two hyperlipidemic mouse strains.

Table 1 Overview of differences in quantitative proteome of ApoE- and LDLR-deficient platelets as compared to wild-type platelets. Highly purified platelets from wild-type, Apoe^−/− and Ldlr^−/− mice were subjected to label-free proteomics analysis. Ratios of 1,533 unique proteins were quantified by mass spectrometry (see “Methods”). Unique proteins of the quantitative proteome were assigned to 22 assumed function classes. Green represents > 1.5 fold downregulated and red > 1.5-fold upregulated proteins. N = 3–4 animals/group.

Full size table

Changes in platelet lipid profiles of ApoE and LDLR deficient mice

Given the common, moderate hyperlipidemic phenotype of both mouse strains (Suppl. Table 1), we also assessed the lipidomic profiles of Apoe^−/−, Ldlr^−/− and wild-type platelets. Quantitative analysis of the lipid classes indicated that especially free cholesterol and cholesteryl esters were elevated in platelets from Apoe^−/− as well as Ldlr^−/− mice (Fig. 7A,B). Additional differences in comparison to wild-type platelets were observed for specific sphingolipids. The sphingolipid precursor ceramide was significantly increased in Apoe^−/− platelets (Fig. 7C). Ceramide incorporates into sphingosine and sphingosine-1-phosphate in the endoplasmic reticulum³⁰, and both were also increased in Apoe^−/− platelets (Fig. 7D,E). In contrast, the level of sphingosine was downregulated in Ldlr^−/− platelets (Fig. 7D). Ceramide is also transported to the Golgi system, where the glycosphingolipids isoforms HexCer and Hex2Cer are formed³⁰. Both isoforms were also significantly increased in Apoe^−/− platelets, but less so in Ldlr^−/− platelets (Fig. 7F,G). No differences were observed for other sphingolipids (Fig. 7H,I). Cluster analysis of the quantitative lipidome analysis highlighted the changes in lipid classes between the three genotype groups (Fig. 7J).

Discussion

In this paper, we investigated the prothrombotic propensity and underlying processes of two (moderately) hyperlipidemic mouse strains, i.e. Apoe^−/− and Ldlr^−/− mice, fed a normal chow diet. Multiparameter measurements of whole blood thrombus and fibrin formation on collagen indicated an exacerbation of the thrombotic process in either knockout strain, when compared to the corresponding wild-type mice. These altered platelet properties were not further aggravated in aged mice, nor by a high-fat diet (Apoe^−/−), i.e. conditions that further elevate the plasma cholesterol levels by 50%. This suggested that a moderate elevation in plasma cholesterol is sufficient to enhance platelet activation and ensuing fibrin formation. Thrombin generation curves and TAT complexes in plasma did not show differences between genotypes, except for a moderate increase in thrombin potential in Apoe^−/− mice, suggesting that the observed effects are primarily due to changes in the platelets themselves. Importantly, bone marrow transplantation of wild-type or Ldlr^−/− platelets into irradiated Ldlr^−/− recipient mice resulted in platelets with a similar gain-of-function in adhesion, activation and thrombus formation, indicating that the hyperlipidemic environment of Ldlr^−/− mice led to an overall increased activation tendency of the chimeric wild-type platelets. Exploration of the platelet proteome revealed overall high similarity between the three genotypes, although some proteins showed significantly increased or decreased expression, particularly in Apoe^−/− mice. Finally, platelets of the mildly hyperlipidemic mice had an altered lipid profile, which is likely to play a role in the observed prothrombotic phenotype.

In the absence of coagulation, both knockout mice demonstrated a prothrombotic phenotype in whole blood perfusion over collagen, but with a different pattern of increased parameters. In comparison to wild-types, Apoe^−/− platelets showed predominantly an increased aggregation tendency and Ldlr^−/− platelets showed increased secretion. Multiparameter measurements of thrombus formation on collagen/TF in the presence of coagulation indicated a strikingly similar enhancement of the thrombotic process in both knockout mice. This agrees with reports that both mouse strains display an aggravated arterial thrombosis tendency in vivo^16,18. Remarkably, the enhancement was also seen on collagen microspots in the absence of TF, which indicates that the prothrombotic phenotype (both coagulation and platelets) has already reached a plateau, and is not further enhanced by TF. This agrees with a platelet-dependent rather than a TF-triggered mechanism of the prothrombotic propensity. Indeed, collagen has been established as a key component of (ruptured) atherosclerotic plaques driving arterial thrombosis in vivo and in vitro^31,32. In addition, the observed increases in platelet activation may stimulate platelet adhesion to other components of the inflamed vessel wall at atherosclerotic plaques³³.

In the blood from aged Ldlr^−/− mice, we observed a minor 6% reduction in platelet deposition on collagen, which related to a 35% lower platelet count (unchanged platelet volume) in these mice, when compared to wild-types. This reduction in platelets was unexpected, since other studies suggest that platelet production is promoted by hypercholesterolemia (reviewed by Wang et al.³⁴). Normal values of murine platelet counts in the literature vary between 450 to 1690 × 10⁹/L³⁵. Given this, the count in all three genotypes was within the normal range. Furthermore, the moderate platelet reduction in Ldlr^−/− does not seem of physiological relevance, since in mouse an 80% reduction in count is needed to affect in vivo arterial thrombus formation³⁶. No relevant differences in leukocyte count were observed, other than an increase in Apoe^−/− mice maintained on high-fat diet, which agrees with a previous report¹¹. Together, our findings are in support of the concept of reactive thrombopoiesis, meaning that megakaryocytes adapt to a changing (lipid) environment, thereby affecting the formed platelets^37,38.

Several studies have reported an enhanced arterial thrombosis tendency in vivo in Apoe^−/− and Ldlr^−/− mice^{16,18,39,40,41}. As we recently demonstrated in a synthesis paper, analyzing over 1400 studies with genetically modified mice, gene deletion effects on thrombus formation in vitro appeared to correlate significantly with the gene deletion effects on arterial thrombosis in vivo⁴². Accordingly, the current findings of a prothrombotic propensity in vitro of (platelets in) Apoe^−/− and Ldlr^−/− blood are fully in line with the earlier detected enhanced thrombosis in these mouse strains. Yet, in translational terms, a limitation of the present study is that Apoe^−/− and Ldlr^−/− mice are still genetic in nature and have a lipid profile that differs from the human situation¹². Although murine platelets differ from human platelets with regard to size, and number, functionally they are very similar^35,43. Furthermore, the interplay of platelet activation and coagulation appears to be remarkably similar between mouse and man^35,42,44. Feeding of wild-type mice with a high-fat diet may be a more physiologically relevant model, although also wild-type mice have a dissimilar lipid profile as compared to humans. Few studies have shown that also in wild-type animals, feeding a high-fat diet results in a prothrombotic phenotype and altered coagulation profile^45,46,47,48. Yet, a translation from mouse studies to the human situation should be treated with caution.

The more enhanced fibrin-thrombus formation of Apoe^−/− mice was accompanied by a limited enhancement of coagulant activity in plasma from these mice. Given the earlier detected alterations in coagulation factor levels in APOE2 knock-in mice⁴⁹, similar changes may be present in the current mouse strain, thus explaining the enhanced thrombin generation potential. Markedly, no alterations in plasmatic coagulation were observed in Ldlr^−/− mice¹¹. However, viscosity and osmolality changes may also contribute to the plasma sensing of platelets in flow studies.

In mouse, hyperlipidemia has been linked to an increased platelet reactivity with proposed roles of oxidized LDL and of the receptor proteins, CD36 and P2Y₁₂^16,50,51,52. The present comparison of the platelet proteome of (mildly hyperlipidemic) Apoe^−/− and Ldlr^−/− mice provides an extension of the first published platelet proteome of wild-type (C57BL/6) platelets⁵³. Using a > 1.5-fold change as criterium for altered protein abundance levels^26,27, some proteins appeared to be up- or downregulated in the knockout platelets, with the changes in Apoe^−/− > > Ldlr^−/−. Changes were mostly confined to Golgi, membrane, signaling and secretory proteins. Regarding the latter class, abundance levels of thrombospondin-2 and complement factors C3 and C4 were upregulated in platelets both knockout mice, while also coagulation factor XIII, reticulon-4, and amyloid beta protein were significantly changed in the Apoe^−/− mice. By themselves, these proteins have been shown to influence platelet function as shown in several functional assays, including those used in the present study (Suppl. Table 4 and references therein). How these proteins in combination alter platelet function is unclear. Of special interest are the complement factors, as these are relevant in thrombo-inflammation⁵⁴, as well as for platelet properties and shedding of microparticles (Suppl. Table 4 and references therein). A recent study showed that C3^−/− mice displayed a prolonged bleeding time, and reduced thrombus formation, fibrin and platelet deposition in the ligated inferior vena cava, and diminished platelet activation in vitro⁵⁵. Furthermore, the binding of C3 to platelets promotes the formation of platelet-leukocyte aggregates⁵⁴.

A major outcome of the platelet lipidome profiling was an increase in cholesterol species in both knock-out mice. In translational terms, this matches with the high cholesterol levels in platelets from patients with hypercholesterolemia⁵⁶. Especially this finding is compatible with a prothrombotic phenotype, as this suggests alterations in membrane fluidity and an increase in membrane lipid rafts in the Apoe^−/− and Ldlr^−/− platelets³⁴. Platelet signaling is indeed considered to be dependent on membrane raft formation^57,58. Another difference in Apoe^−/− and Ldlr^−/− platelets compared to wild-types were (distinct) changes in levels of (glyco)sphingolipids. While an altered sphingolipid metabolism can modulate platelet activation⁵⁹, precisely how is still unclear. Options in the current context are effects of sphingolipid species on lipid sorting in the Golgi apparatus, or effects on lipid degradation in the lysosomes.

Hyperlipidemia is associated with shortened platelet survival and increased turnover in man³⁴ and mouse³⁷. However, our bone marrow transplantation experiment, in combination with only minor changes in the total platelet proteome, suggests that altered platelet protein function, not platelet count, is a major factor in the prothrombotic effects of hyperlipidemia. These changes in protein activity can be caused by post-translational modifications (PTMs), which regulate protein activity and are also effective in platelets. These PTMs include phosphorylation, glycosylation, palmitoylation, ubiquitination and oxidative stress, all of which have been described to alter platelet proteins during hemostasis as well as in several diseases including hyperlipidemia⁶⁰. Although both hyperlipidemic mouse strains show a prothrombotic phenotype, we also observed differences between the Apoe^−/− and Ldlr^−/− platelets in several measurements, as indicated above. One explanation for this may be the different lipoprotein profiles of Apoe^−/− and Ldlr^−/− mice, being mainly VLDL and chylomicrons particles or LDL, respectively¹². The effects of (oxidized) LDL on platelet function has been well established⁶¹, and also some studies have shown that VLDL induces platelet aggregation^62,63. As different classes of lipoproteins have been shown to differently affect (human) platelet activation, the dissimilar balance in lipoprotein classes between both knockout strains may also explain the observed subtle differences in platelet activation. Furthermore, we postulate that different PTMs may be induced by LDL and VLDL.

Taken together, we conclude that the prothrombotic phenotype of mouse platelets in a mildly hyperlipidemic environment is triggered by the lipid surroundings, resulting in moderate changes in lipid abundance levels. The positive priming of platelets in hyperlipidemia increases their responsiveness and enhances platelet-dependent coagulation and fibrin clot formation under flow. In a translational perspective, it will be important to extend the study to humans with moderately elevated cholesterol levels.

Methods

Animals

All animal work was approved by the Maastricht University Animal Ethics Committee and the animal experiments were performed conform the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes. Wild-type C57BL/6J, Apoe^−/− and Ldlr^−/− mice (Charles River, Sulzfeld, Germany) of the same genetic background were used in age groups of 9–12 (young) or 37–42 (aged) weeks old. Male and female mice were included at random. Animals were socially housed in standard cages, exposed to a 12 h light/darkness cycle, and given ad libitum access to water and food. Where indicated, Apoe^−/− mice (10 weeks old) were fed with normal chow diet or with a cholate-free, high-fat diet (Arie Blok Diet W, Woerden, The Netherlands), consisting of (w/w) cocoa butter (15%), cholesterol (0.25%), sucrose (40.5%), corn starch (10%), corn oil (1%), cellulose (5.95%), casein (20%), 50% choline chloride (2%), methionine (0.2%) and mineral mixture (5.1%) with a total fat content of 16%^64,65. For bone marrow transplantation, 1 × 10⁷ bone marrow cells obtained from wild type C57BL/6 J or Ldlr^−/− donor mice were injected into irradiated (2 × 6 Gy) Ldlr^−/− recipient mice⁶⁴.

Blood collection and processing

Mice were anaesthetized by subcutaneous injection of 100 mg/kg body weight ketamine and 0.5 mg/kg body weight medetomidine. Blood was taken through retro-orbital puncture, with 9 volumes collected into one volume of 129 mM trisodium citrate⁶⁶, after which mice were euthanized by cervical dislocation. Where indicated, blood was collected into 300 µl PPACK/fragmin anticoagulant solution, containing saline, H-Phe-Pro-Arg chloromethyl ketone (PPACK, 40 μM), low molecular weight heparin (fragmin, 40 U/ml, Pfizer, Capelle a/d IJssel, The Netherlands) and heparin (5 units/ml, Sigma-Aldrich, St. Louis MO, USA)⁶⁷. For the preparation of washed platelets, blood was collected 6:1 (vol./vol.) into acid citrate-dextrose solution (ACD, 80 mM sodium citrate, 52 mM citric acid, 183 mM D-glucose). Hematological blood parameters were determined in citrated blood using a Sysmex blood analyzer (Europe, Norderstedt, Germany). Platelet-free plasma (citrated) was stored at − 80 °C for later assessment of lipids and coagulation parameters.

Real-time assessment of platelet–fibrin thrombus formation under flow

Our method to assess whole blood thrombus formation under coagulant conditions at defined wall shear rate²³, was extended to a multiparameter assay²⁴, and adapted for mouse blood. In brief, coverslips were coated with two separate surfaces. In the direction of flow: microspot Ma: collagen type I (2 μl, 50 μg/ml); and Mb: collagen type I + tissue factor (TF, 2 μl, 500 pM). After blocking with Tyrode's Hepes buffer pH 7.45 (5 mM Hepes, 136 NaCl, 2.7 mM KCl, 2 mM MgCl₂, 0.42 NaH₂PO₄, 1 mg/mL glucose, 5 units/mL heparin) containing 1% BSA, the coverslips were mounted onto a parallel-plate flow chamber with precisely defined dimensions (depth 50 μm, width 3 mm and length 30 mm)¹⁹. Perfusion with recalcified citrated blood was performed until 6 min at a shear rate of 1000 s⁻¹. Recalcification medium consisted of 63 mM CaCl₂ and 32 mM MgCl₂ in Tyrode's Hepes buffer; mixing with the blood was via a flattened Y-shaped dual inlet tube²³. Before each experiment, blood samples (500 μl) were pre-labeled with DiOC₆ (0.5 μg/mL, AnaSpec, San Jose CA, USA) and Alexa Fluor (AF) 647-labeled human fibrinogen (10 μg/mL, Molecular Probes, Bleiswijk, The Netherlands). Fluorescence (confocal) microscopic images were captured in two or three colors at 45 s intervals, to evaluate kinetics.

Multiparameter assessment of platelet activation and aggregation under flow

Platelet adhesion and aggregation in perfused whole blood was measured under non-coagulant conditions as described^19,24, but adapted for murine blood. Coverslips were coated with a microspot (0.5 µl) of collagen type I (100 µg/ml) and mounted onto a flow chamber, and perfused with PPACK/fragmin-anticoagulated blood for 3.5 min at a wall shear rate of 1000 s⁻¹. Platelets were stained according to a stringent protocol by 2 min post-perfusion with Tyrode's Hepes buffer pH 7.45 (5 mM Hepes, 136 NaCl, 2.7 mM KCl, 2 mM MgCl₂, 0.42 NaH₂PO₄, 2 mM CaCl₂, 1 mg/mL glucose, 1 U/mL heparin, and 1 mg/mL BSA), supplemented with fluorescein isothiocyanate (FITC)-labeled rat anti-mouse CD62P mAb (1:40, Emfret Analytics, Würzburg, Germany), phycoerythrin (PE) labeled rat anti-mouse JON/A mAb (1:20, Emfret Analytics), and AF647 labeled annexin A5 (1:200, Invitrogen Life Technologies, Carlsbad, CA, USA). Representative end-stage brightfield microscopic images were taken from each microspot during staining. After 2 min of stasis, remaining labels were washed away by perfusion with label-free Tyrode's Hepes buffer, after which three representative end-stage fluorescence images were collected per microspot.

Real-time microscopic image collection and quantitative image analysis

Microscopic images (1360 × 1024 pixels, 142 × 107 μm, 8-bit) were recorded with an EVOS fluorescence microscope (Life Technologies, Carlsbad CA, USA), equipped with GFP, RFP and Cy5 LED cubes, and an Olympus 60 × oil-immersion objective, basically as described¹⁹. For specific kinetic measurements, confocal fluorescence images were recorded with a LSM7 Live line-scanning system from Carl Zeiss (Jena, Germany)²³.

Brightfield images, collected under non-coagulating conditions, were analyzed for the following parameters¹⁹: morphological score (P1, scale 0–5); percentage surface area coverage of deposited platelets (P2, % SAC), platelet aggregate contraction score (P3, scale 0–3), aggregate multilayer score (P4, scale 0–3), and aggregate multilayer coverage (P5, % SAC). Scores were compared against redefined standard images. Raw fluorescence images were analyzed for PS exposure (P6, % SAC), P-selectin expression (P7, % SAC) and integrin α_IIbβ₃ activation (P8, % SAC). Images were examined by several observers. Two-color fluorescence images, collected under coagulating conditions, were analyzed for DiOC₆ platelet deposition (Pa, % SAC); DiOC₆ platelet thrombus score (Pb, scale 0–5); time to first fibrin formation (Pc, − log min); AF647 fibrin score (Pd, scale 0–3) and AF647 fibrin-covered area (Pe, % SAC).

Values of SAC from brightfield and fluorescence images were determined, using specific scripts in Fiji software (Laboratory for Optical and Computational Instrumentation, University of Wisconsin-Madison WI, USA). Processing was as single color, gray images, either in 8-bit (brightfield) or in 24-bit (GFP, RFP or Cy5 fluorescence). Scripts opened series of one-color images using a loop. In each run, background illumination was corrected using a fast Fourier transform bandpass (FFTB) filter; this was followed by a threshold setting (with manual adjustment) and a surface area coverage measurement. For brightfield images, a series of Gray morphology conversions was applied to reduce striping and improve the detection (a diamond large-sized close, followed by a medium-sized circle close and a small circle-shaped dilate). The first step increased the pixels yet stronger in regions with many neighboring pixels, the second step rounded the shapes and additionally reduced straight lines, while the final step could be altered by user interface to match the overlap with unprocessed images. The FFTB filter sizes were selected to have minimal impact on the image structures, but flatten the background areas sufficiently for good analysis. For both brightfield and fluorescence channels, large structures were filtered down to 60–200 pixels, as appropriate per channel. Small structures were not filtered down, as these contained details of structures of interest within the platelets.

Multiparameter data processing

For each flow run, parameter values from individual brightfield and fluorescence images were averaged to obtain one value per parameter per microspot. For the complete database of all runs, these values were linearly normalized to a scale from 0–10 per individual parameter. Gene effect heatmaps were obtained by subtracting per parameter the normalized average wild type values from the normalized average values of Apoe^−/− or Ldlr^−/− mice. Differences compared to wildtype were considered statistically significant with P < 0.05 (t test, 2-sided, equal variance) after correction for multiple comparisons, where required.

Effect sizes per parameter and genotype were calculated according to Cohen’s d: d = (x͂₁ − x͂₂)/s, in which the raw data per flow run were used to calculate the pooled standard deviation s, taking the equation: s = √(((n₁-1) s₁² + (n₂-1) s₂²)/(n₁ + n₂-2)). Subsequently, regression coefficients r were determined by the equation r = d/√(d² + a), in which a represents the correction factor if n₁ ≠ n₂, calculated by the equation: a = (n₁ + n₂)²/n₁n₂⁶⁸. Normalized average and effect size heatmaps were produced using the R package version 3.2.5 (www.r-project.org).

Flow cytometry

Flow cytometry with washed mouse platelets was performed with an Accuri C6 flow cytometer (Becton Dickinson, Ann Arbor MI, USA), as described⁶⁷. Platelets (1 × 10⁸/mL) suspended in Tyrode's Hepes buffer pH 7.45 containing 2 mM CaCl₂ were stimulated with convulxin (25–100 ng/mL)⁶⁹, cross-linked collagen related peptide (CRP-XL, 0.5–5.0 μg/mL), methyl-thio-ADP (Me-S-ADP, 0.25–10 µM; Hart Biologicals, Hartlepool, UK), or thrombin (0.5–4.0 nM; Kordia, Leiden, The Netherlands), without stirring. Unstimulated samples were used as controls. After 15 min incubation, α-granule secretion was detected with FITC-labeled anti-CD62P mAb (1:10, Emfret Analytics, Wurzburg, Germany), integrin α_IIbβ₃ activation with PE-labeled rat anti-mouse JON/A mAb (1:10, Emfret Analytics), and PS exposure with AF647-annexin A5 (1:200, Molecular Probes).

Plasma lipids and coagulant activity

Platelet-free plasma was obtained by double centrifugation and stored at − 80 °C, as described before⁷⁰. After thawing, plasma triglycerides were determined with a Triglycerides FS5 Ecoline kit from DiaSys (Diagnostic Systems, Holzheim, Germany); plasma cholesterol was measured with a Cholesterol FS10 kit from DiaSys. Thrombin-antithrombin (TAT) complexes in plasmas were measured with an Enzygnost TAT micro-kit from Siemens (Erlangen, Germany). Kits were used according to the manufacturer’s instructions.

Calibrated automated thrombin generation

Thrombin generation with platelet-free plasma was performed using a 96 well plate-based assay, essentially following a published method⁷¹. Briefly, 20 μL of murine plasma was mixed with 10 μL of pre-trigger medium containing 7 pM tissue factor (Dade Innovin, Siemens, the Hague, The Netherlands), 0.83 mg/mL BSA, and 60 μM phospholipid mixture (PS/PE/PC, 20/60/20, w/w/w) in 25 mM Hepes plus 165 mM NaCl (pH 7.5). Mixtures were incubated at 37 °C for 7 min, and then supplemented with recalcification buffer containing chromogenic thrombin substrate or α_2M-thrombin calibrator⁷¹. Thrombin generation was immediately calculated per well using Thrombinoscope software (Maastricht, The Netherlands).

Preparation of highly purified platelets for proteomics or lipidomics

Sample preparation for proteomic and lipidomic analysis was performed, as described for human blood²⁹, with adjustments for mouse blood to maximize purified platelet yield. In brief, platelets for proteomics were prepared from ACD-anticoagulated blood from one animal in an Eppendorf tube, which was supplemented with EGTA (0.5 mM) and apyrase (0.2 U/mL). Platelets for lipidomic analysis were prepared from citrate-anticoagulated blood. After centrifugation at 264 g for 5 min, the platelet-rich plasma (PRP) with the top 30% of red blood cells was transferred to a new tube. PRP was obtained by centrifugation at 80 g for 6 min, and transferred to a new tube. After addition of 200 μL Tyrode's Hepes buffer (137 mM NaCl, 2 mM KCl, 12 mM NaHCO₃, 0.3 mM NaH₂PO₄, 5.5 mM glucose, 5 mM Hepes, pH 7.4) to the remaining 30% red blood cells, a second lot of PRP was obtained by another centrifugation step as above. The combined PRP samples were supplemented with ACD and apyrase, and centrifuged at 720 g for 6 min. The pelleted platelets were carefully resuspended into an adequate volume of Tyrode's Hepes buffer containing ACD (1:10) and apyrase (1 U/mL), leaving the red cell pellet untouched, transferred to a clean Eppendorf tube and centrifuged again. This procedure was repeated, if necessary, to remove residual red and white blood cells.

For proteomic analyses platelets were isolated from 4 wild-type, 4 Apoe^−/− and 3 Ldlr^−/− mice, and the final platelet pellet was resuspended in 150 µL Tyrode's Hepes buffer. Purity of the platelet suspension was verified using a Sysmex blood analyzer and by microscopic analysis, and approved when contamination of red cells and leukocytes was < 1:15,000 and < 1:20,000, respectively, in agreement with previously published data¹². The pure platelet samples were lysed with lysis buffer 1:1 pH 7.8 (50 mM Tris, 1% SDS, 150 mM NaCl, 1 tablet PhosStop/7 mL; Roche, Basel, Switzerland) containing a mixture of protease and phosphatase inhibitors (10 mM sodium orthovanadate (Na₃VO₄, Sigma-Aldrich, St. Louis MO, USA) 4 mM phenylmethylsulfonyl fluoride (ThermoFisher Scientific, Breda, The Netherlands), 20 μg/mL leupeptin (VWR, Amsterdam, The Netherlands), 5 μg/mL pepstatin (VWR, Amsterdam, The Netherlands) and 4 mM EDTA). Lysed samples were immediately snapfrozen and stored at − 80 °C until use.

For lipidomic analysis the final platelet pellet and the supernatant were separated and immediately snapfrozen and stored at − 80 °C until usage for lipidomics analysis, which was performed basically as described⁵⁹. During the procedures, blank extractions were performed for all analysis to detect possible contamination which could lead to false positive identification. Platelets in the analyzed preparations were unstimulated, verified by the low amounts of secreted 12-HETE (all samples below 400 pmol/mg protein) and thromboxane B₂ (all below 45 pmol/mg protein).

Proteomic analysis

A label-free quantification analysis was performed with mouse platelet samples, as described before²⁹. In short, the protein concentration of well-purified platelet samples (277–1390 × 10⁹/L) in 1% SDS lysis buffer was estimated using the Bicinchoninic acid assay kit (Pierce, Thermo-Fisher Scientific, Bremen, Germany). After equalizing protein concentration, proteins were reduced with dithiothreitol and free sulfhydryl groups were alkylated with iodoacetamide. Subsequently, 20 µg of protein sample were processed using filter-aided sample preparation (FASP), with a 30 kDa molecular weight cut-off spin filter. Thus, digestion was conducted with 50 mM ammonium bicarbonate, 200 mM guanidinium hydrochloride and 2 mM CaCl2, pH 7.8 in the presence of trypsin (1:20 w/w, sequencing grade trypsin Promega, Madison WI, USA) for 14 h at 37 °C. Trypsin digestion was monitored by monolithic reversed phase HPLC⁷². For label free analysis 2 µg of peptide, were analyzed by nano LC–MS/MS in DDA mode using a U3000 nano-RSLC system online-coupled to an Orbitrap Lumos mass spectrometer. Thus, peptides were loaded onto a trap column (Acclaim PepMap 100 C18; 100 μm × 2 cm) with 0.1% trifluoroacetic acid (TFA). Then, peptides were separated on the main column (PepMap 100 C18; 75 μm × 50 cm), using a binary gradient ranging from 3–45% solvent B (84% acetonitrile, 0.1% formic acid) in 150 min at 60 °C and a flow rate of 250 nL/min. In the Lumos Orbitrap survey scans were acquired in the Orbitrap at resolution of 120,000 FWHM, with an AGC target of 2 × 105 and a maximum injection time of 50 ms. Data dependent MS/MS was performed using Top speed parameter with 3 s cycle time of the most intense signals using monoisotopic peak determination and an intensity threshold of 5 × 10³, a dynamic exclusion of 15 s and an isolation window of 1.2 m/z using the quadrupole. Thus, peptide fragments were acquired in the ion trap in rapid scan mode with a first fixed mass of 120 m/z after fragmentation by Higher collision induced dissociation with 30% normalized collision energy. Additionally, an automatic gain control target value of 2 × 10³ and maximum injection time of 300 ms with Inject ion for all available parallelizable time were used.

For label free quantification the Progenesis LC–MS software version 4.1 from Nonlinear Dynamics (Newcastle upon Tyne, UK) was used. Consequently, MS raw data were aligned in automatic mode. Exported peak lists were searched using SearchGUI 3.3.3, Mascot 2.6 (Matrix Science), X! TANDEM Vengeance (2015.12.15.2) and MS-GF + Release (v2018.04.09), with a concatenated target/decoy version of the mouse Uniprot database (July 2015, containing 16,716 sequences). Data analysis was done using PeptideShaker 1.16.23 (http://code.google.com/p/peptide-shaker/), in order to maximize number of identified peptides and proteins. The following search parameters were used: trypsin as protease with a maximum of two missed cleavages; carbamidomethylation of Cys (57.021464) as fixed and as variable modification oxidation of Met (15.994915), acetylation of protein N-term and acetylation of K (42.010565). MS and MS/MS tolerances were set to 10 ppm and 0.5 Da. In PeptideShaker, search results were combined and filtered at a FDR of 1% (high confidence filter) on the protein level prior to export and re-import into Progenesis. Peptide sequences containing pyro-Glu (derived from X!Tandem 2nd pass search), oxidized methionine and acetylation of lysine and protein N-terminal were omitted from further data analysis. Only proteins with at least two unique peptides were considered for quantification. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE⁷³ partner repository with the dataset identifier PXD020276. For comparison between platelets from both knockout against wild-type mice described common platelet contaminant proteins⁵³ were removed and raw values were normalized. After normalization, a log 2 ratio was calculated, as well as P values (t test). In total, 1,533 proteins were quantified and regulated proteins were defined as 1.5-fold up- or downregulated.

Statistics

Data are presented as means ± SEM. Comparisons between age, diet and mouse genotypes (knock-out compared to wild-type) were made using the Mann Whitney U-test or the Kruskal–Wallis test for continuous variables. As we have shown previously, the majority of parameters tended to correlate positively per microspot, suggesting a 'thrombus profile' represented by multiple parameters²⁴. Therefore, datasets were compared using Pearson or Spearman correlation analysis, as described²⁴.

For proteomic analysis, a t-test was used after normalization to compare up-or downregulated proteins between wild-type and knock-out mice. As multiple hypotheses were tested simultaneously, we corrected for multiple testing and controlled the false discovery rate (FDR; 0.05) with the Benjamini–Hochberg procedure, which adapts to the amount of signal in the data. The statistical package for social science version 22 was used (SPSS 22, Chicago IL, USA), with a P value < 0.05 considered to be significant.

References

World-Health-Organization. Fact sheet cardiovascular diseases, (2017). Available at http://www.who.int/mediacentre/factsheets/fs317/en/ Accessed July 3, 2020.
Roth, G. A. et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 132, 1667–1678 (2015).
Article PubMed Google Scholar
National Heart, Lung, and Blood Institute. National Institutes of Health; U.S. Department of Health and Human Services. High Blood cholesterol: what you need to know (2005). Available at https://www.nhlbi.nih.gov/files/docs/public/heart/wyntk.pdf. Accessed July 3, 2020.
National Heart, Lung, and Blood Institute. National Institutes of Health; U.S. Department of Health and Human Services. High Blood Triglycerides (2005). Available at https://www.nhlbi.nih.gov/health-topics/high-blood-triglycerides. Accessed July 3, 2020.
Benjamin, E. J. et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135, e146–e603 (2017).
Article PubMed PubMed Central Google Scholar
World-Health-Organization. Global Health Observatory (GHO) data: raised cholesterol, (2014). Available at https://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/ Accessed July 3, 2020.
Palasubramaniam, J., Wang, X. & Peter, K. Myocardial infarction-from atherosclerosis to thrombosis. Arterioscl. Thromb. Vasc. Biol. 39, e176–e185 (2019).
Article CAS PubMed Google Scholar
Libby, P. & Hansson, G. K. From focal lipid storage to systemic inflammation: JACC review topic of the week. J. Am. Coll. Cardiol. 74, 1594–1607 (2019).
Article CAS PubMed PubMed Central Google Scholar
Wu, K. K., Armstrong, M. L., Hoak, J. C. & Megan, M. B. Platelet aggregates in hypercholesterolemic rhesus monkeys. Thromb. Res. 7, 917–924 (1975).
Article CAS PubMed Google Scholar
Wouters, K., Shiri-Sverdlov, R., van Gorp, P. J., van Bilsen, M. & Hofker, M. H. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Clin. Chem. Lab. Med. 43, 470–479 (2005).
Article CAS PubMed Google Scholar
Getz, G. S. & Reardon, C. A. Do the Apoe^−/− and Ldlr^−/− mice yield the same insight on atherogenesis?. Arterioscl. Thromb. Vasc. Biol. 36, 1734–1741 (2016).
Article CAS PubMed Google Scholar
Oppi, S., Luscher, T. F. & Stein, S. Mouse models for atherosclerosis research—Which is my line?. Front. Cardiovasc. Med. 6, 46 (2019).
Article CAS PubMed PubMed Central Google Scholar
He, K. et al. An interspecies study of lipid profiles and atherosclerosis in familial hypercholesterolemia animal models with low-density lipoprotein receptor deficiency. Am. J. Transl. Res. 11, 3116–3127 (2019).
CAS PubMed PubMed Central Google Scholar
Plump, A. S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 (1992).
Article CAS PubMed Google Scholar
Zhang, S. H., Reddick, R. L., Piedrahita, J. A. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468–471 (1992).
Article ADS CAS PubMed Google Scholar
Podrez, E. A. et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat. Med. 13, 1086–1095 (2007).
Article CAS PubMed PubMed Central Google Scholar
Ishibashi, S. et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Investig. 92, 883–893 (1993).
Article CAS PubMed Google Scholar
Schafer, K. et al. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1. Arterioscl. Thromb. Vasc. Biol. 23, 2097–2103 (2003).
Article CAS PubMed Google Scholar
de Witt, S. M. et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat. Commun. 5, 4257 (2014).
Article ADS CAS PubMed PubMed Central Google Scholar
Hemmeryckx, B., Emmerechts, J., Bovill, E. G., Hoylaerts, M. F. & Lijnen, H. R. Effect of ageing on the murine venous circulation. Histochem. Cell Biol. 137, 537–546 (2012).
Article CAS PubMed Google Scholar
Versteeg, H. H., Heemskerk, J. W., Levi, M. & Reitsma, P. H. New fundamentals in hemostasis. Physiol. Rev. 93, 327–358 (2013).
Article CAS PubMed Google Scholar
Eitzman, D. T., Westrick, R. J., Xu, Z., Tyson, J. & Ginsburg, D. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscl. Thromb. Vasc. Biol. 20, 1831–1834 (2000).
Article CAS PubMed Google Scholar
Swieringa, F. et al. Platelet control of fibrin distribution and microelasticity in thrombus formation under flow. Arterioscl. Thromb. Vasc. Biol. 36, 692–699 (2016).
Article CAS PubMed Google Scholar
van Geffen, J. P. et al. High-throughput elucidation of thrombus formation reveals sources of platelet function variability. Haematologica 104, 1256–1267 (2019).
Article CAS PubMed PubMed Central Google Scholar
Sommeijer, D. W. et al. Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes. Thromb. J. 3, 12 (2005).
Article CAS PubMed PubMed Central Google Scholar
Sabrkhany, S. et al. Exploration of the platelet proteome in patients with early-stage cancer. J. Proteom. 177, 65–74 (2018).
Article CAS Google Scholar
Izquierdo, I. et al. A comprehensive tyrosine phosphoproteomic analysis reveals novel components of the platelet CLEC-2 signaling cascade. Thromb. Haemost. 120, 262–276 (2020).
Article PubMed Google Scholar
Burkhart, J. M. et al. What can proteomics tell us about platelets?. Circ. Res. 114, 1204–1219 (2014).
Article CAS PubMed Google Scholar
Solari, F. A. et al. Combined quantification of the global proteome, phosphoproteome, and proteolytic cleavage to characterize altered platelet functions in the human Scott syndrome. Mol. Cell Proteom. 15, 3154–3169 (2016).
Article CAS Google Scholar
Iqbal, J., Walsh, M. T., Hammad, S. M. & Hussain, M. M. Sphingolipids and lipoproteins in health and metabolic disorders. Trends Endocrinol. Metab. 28, 506–518 (2017).
Article CAS PubMed PubMed Central Google Scholar
Kuijpers, M. J. et al. Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model. J. Thromb. Haemost. 7, 152–161 (2009).
Article CAS PubMed Google Scholar
Cosemans, J. M. et al. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 181, 19–27 (2005).
Article CAS PubMed Google Scholar
Massberg, S. et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112, 1180–1188 (2005).
Article CAS PubMed Google Scholar
Wang, N. & Tall, A. R. Cholesterol in platelet biogenesis and activation. Blood 127, 1949–1953 (2016).
Article CAS PubMed PubMed Central Google Scholar
Tsakiris, D. A., Scudder, L., Hodivala-Dilke, K., Hynes, R. O. & Coller, B. S. Hemostasis in the mouse (Mus musculus): a review. Thromb. Haemost. 81, 177–188 (1999).
Article CAS PubMed Google Scholar
Morowski, M. et al. Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice. Blood 121, 4938–4947 (2013).
Article CAS PubMed Google Scholar
Murphy, A. J. et al. Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis. Nat. Med. 19, 586–594 (2013).
Article CAS PubMed PubMed Central Google Scholar
van der Meijden, P. E. J. & Heemskerk, J. W. M. Platelet biology and functions: new concepts and clinical perspectives. Nat. Rev. Cardiol. 16, 166–179 (2019).
Article CAS PubMed Google Scholar
Jiang, P. et al. The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis. Thromb. Res. 133, 657–666 (2014).
Article CAS PubMed Google Scholar
Huang, Z. S. et al. Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase. J. Thromb. Haemost. 8, 1383–1393 (2010).
Article CAS PubMed Google Scholar
Zhu, L. et al. Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1039–1045 (2009).
Article CAS PubMed PubMed Central Google Scholar
Baaten, C. et al. A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding. Blood 132, e35–e46 (2018).
Article CAS PubMed PubMed Central Google Scholar
Jirouskova, M., Shet, A. S. & Johnson, G. J. A guide to murine platelet structure, function, assays, and genetic alterations. J. Thromb. Haemost. 5, 661–669 (2007).
Article CAS PubMed Google Scholar
Berny, M. A. et al. Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. PLoS ONE 5, e10415 (2010).
Article ADS CAS PubMed PubMed Central Google Scholar
Cleuren, A. C. et al. Changes in dietary fat content rapidly alters the mouse plasma coagulation profile without affecting relative transcript levels of coagulation factors. PLoS ONE 10, e0131859 (2015).
Article CAS PubMed PubMed Central Google Scholar
Chen, K. et al. Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. Blood 117, 5744–5750 (2011).
Article CAS PubMed PubMed Central Google Scholar
Monteiro, P. F. et al. Platelet hyperaggregability in high-fat fed rats: a role for intraplatelet reactive-oxygen species production. Cardiovasc. Diabetol. 11, 5 (2012).
Article CAS PubMed PubMed Central Google Scholar
Su, X., Yu, X., Chen, R. & Bian, W. Swimming improves platelet dysfunction in mice fed with a high-fat diet. Arch. Physiol. Biochem. https://doi.org/10.1080/13813455.2020.1808996 (2020).
Article PubMed Google Scholar
Vanschoonbeek, K. et al. Anticoagulant effect of dietary fish oil in hyperlipidemia: a study of hepatic gene expression in APOE2 knock-in mice. Arterioscler. Thromb. Vasc. Biol. 28, 2023–2029 (2008).
Article CAS PubMed Google Scholar
Nagy, B., Jin, J., Ashby, B., Reilly, M. P. & Kunapuli, S. P. Contribution of the P2Y₁₂ receptor-mediated pathway to platelet hyperreactivity in hypercholesterolemia. J. Thromb. Haemost. 9, 810–819 (2011).
Article CAS PubMed PubMed Central Google Scholar
Magwenzi, S. et al. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. Blood 125, 2693–2703 (2015).
Article CAS PubMed PubMed Central Google Scholar
Yang, M. et al. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo. Blood Adv. 2, 2848–2861 (2018).
Article CAS PubMed PubMed Central Google Scholar
Zeiler, M., Moser, M. & Mann, M. Copy number analysis of the murine platelet proteome spanning the complete abundance range. Mol. Cell Proteom. 13, 3435–3445 (2014).
Article CAS Google Scholar
Eriksson, O., Mohlin, C., Nilsson, B. & Ekdahl, K. N. The human platelet as an innate immune cell: interactions between activated platelets and the complement system. Front. Immunol. 10, 1590 (2019).
Article CAS PubMed PubMed Central Google Scholar
Subramaniam, S. et al. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 129, 2291–2302 (2017).
Article CAS PubMed PubMed Central Google Scholar
Panes, O. et al. Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin. Atherosclerosis 257, 164–171 (2017).
Article CAS PubMed Google Scholar
Locke, D., Chen, H., Liu, Y., Liu, C. & Kahn, M. L. Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI. J. Biol. Chem. 277, 18801–18809 (2002).
Article CAS PubMed Google Scholar
Bodin, S., Tronchere, H. & Payrastre, B. Lipid rafts are critical membrane domains in blood platelet activation processes. Biochim. Biophys. Acta 1610, 247–257 (2003).
Article CAS PubMed Google Scholar
Peng, B. et al. Identification of key lipids critical for platelet activation by comprehensive analysis of the platelet lipidome. Blood 132, e1–e12 (2018).
Article CAS PubMed PubMed Central Google Scholar
Gianazza, E. et al. Platelets in healthy and disease states: from biomarkers discovery to drug targets identification by proteomics. Int. J. Mol. Sci. 21, 4541 (2020).
Article CAS PubMed Central Google Scholar
Akkerman, J. W. From low-density lipoprotein to platelet activation. Int. J. Biochem. Cell Biol. 40, 2374–2378 (2008).
Article CAS PubMed Google Scholar
Orth, M., Luley, C. & Wieland, H. Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability. Thromb. Res. 79, 297–305 (1995).
Article CAS PubMed Google Scholar
Mochizuki, M. et al. The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons. Thromb. Res. 81, 583–593 (1996).
Article CAS PubMed Google Scholar
Marsch, E. et al. Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia. Eur. Heart J. 37, 2993–2997 (2016).
Article CAS PubMed PubMed Central Google Scholar
Haasdijk, R. A. et al. THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE-/- mice. Cardiovasc. Res. 110, 129–139 (2016).
Article CAS Google Scholar
Swieringa, F., Kuijpers, M. J., Lamers, M. M., van der Meijden, P. E. & Heemskerk, J. W. Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow. Haematologica 100, 748–756 (2015).
Article CAS PubMed PubMed Central Google Scholar
Kuijpers, M. J. et al. Platelet CD40L modulates thrombus growth via phosphatidylinositol 3-kinase b, and not via CD40 and IkB kinase a. Arterioscler. Thromb. Vasc. Biol. 35, 1374–1381 (2015).
Article CAS PubMed Google Scholar
Nieminen, P., Lehtiniemi, H., Vähäkangas, K., Huusko, A. & Rautio, A. Standardised regression coefficient as an effect size index in summarising findings in epidemiological studies. Epidemiol. Biostat. Publ. Health 10, 15 (2013).
Google Scholar
Siljander, P. et al. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: involvement of p38 MAP kinase and calpain. Arterioscler. Thromb. Vasc. Biol. 21, 618–627 (2001).
Article CAS PubMed Google Scholar
Gilio, K. et al. Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. J. Biol. Chem. 285, 23410–23419 (2010).
Article CAS PubMed PubMed Central Google Scholar
Tchaikovski, S. N., van Vlijmen, B. J., Rosing, J. & Tans, G. Development of a calibrated automated thrombography based thrombin generation test in mouse plasma. J. Thromb. Haemost. 5, 2079–2086 (2007).
Article CAS PubMed Google Scholar
Burkhart, J. M., Schumbrutzki, C., Wortelkamp, S., Sickmann, A. & Zahedi, R. P. Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J. Proteom. 75, 1454–1462 (2012).
Article CAS Google Scholar
Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442–D450 (2019).
Article CAS Google Scholar

Download references

Acknowledgements

We thank Dr. Remco Verdoold for experienced support with digital image analysis, and Stella C. M. Thomassen for expert help with thrombin generation experiments. The studies were supported by the Centre for Translational Molecular Medicine (CTMM), Innovative Coagulation Diagnostics, and the Cardiovascular Centre (HVC), Maastricht University Medical Centre. Authors received further support from the de.NBI BMBF initiative grants No 031L0108A and 031A534B, and the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands
Johanna P. van Geffen, Frauke Swieringa, Bibian M. E. Tullemans, Johan W. M. Heemskerk & Marijke J. E. Kuijpers
Leibniz Institut für Analytische Wissenschaften – ISAS– e.V, Dortmund, Germany
Frauke Swieringa, Fiorella A. Solari, Bing Peng, Albert Sickmann, René P. Zahedi & Robert Ahrends
Department of Pathology, CARIM, Maastricht University, Maastricht, The Netherlands
Kim van Kuijk, Erik A. L. Biessen & Judith C. Sluimer
Department of Haematology, Inselspital, University of Bern, Bern, Switzerland
Kenneth J. Clemetson
Department of Biochemistry, University of Cambridge, Cambridge, UK
Richard W. Farndale
The M-Lab, Department of Precision Medicine, School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands
Ludwig J. Dubois
Segal Cancer Proteomics Centre, Jewish General Hospital, McGill University, Montreal, Canada
René P. Zahedi
Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Wien, Austria
Robert Ahrends
Institute for Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany
Erik A. L. Biessen
BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK
Judith C. Sluimer

Authors

Johanna P. van Geffen
View author publications
You can also search for this author in PubMed Google Scholar
Frauke Swieringa
View author publications
You can also search for this author in PubMed Google Scholar
Kim van Kuijk
View author publications
You can also search for this author in PubMed Google Scholar
Bibian M. E. Tullemans
View author publications
You can also search for this author in PubMed Google Scholar
Fiorella A. Solari
View author publications
You can also search for this author in PubMed Google Scholar
Bing Peng
View author publications
You can also search for this author in PubMed Google Scholar
Kenneth J. Clemetson
View author publications
You can also search for this author in PubMed Google Scholar
Richard W. Farndale
View author publications
You can also search for this author in PubMed Google Scholar
Ludwig J. Dubois
View author publications
You can also search for this author in PubMed Google Scholar
Albert Sickmann
View author publications
You can also search for this author in PubMed Google Scholar
René P. Zahedi
View author publications
You can also search for this author in PubMed Google Scholar
Robert Ahrends
View author publications
You can also search for this author in PubMed Google Scholar
Erik A. L. Biessen
View author publications
You can also search for this author in PubMed Google Scholar
Judith C. Sluimer
View author publications
You can also search for this author in PubMed Google Scholar
Johan W. M. Heemskerk
View author publications
You can also search for this author in PubMed Google Scholar
Marijke J. E. Kuijpers
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

J.G., F.S. and M.K. performed experiments, analyzed the data and wrote the manuscript. K.V.K and B.T. performed experiments and analyzed data. F.A.S., A.S. and R.Z. collected, analyzed and supervised proteomics data. B.P. and R.A. collected, analyzed and supervised lipidomics data. K.C. and R.W. provided thrombogenic surfaces. E.B. and J.C. supervised mouse experiments. J.H. and M.K. provided expert supervision and wrote the manuscript. All authors have read and approved the final version of the manuscript.

Corresponding author

Correspondence to Marijke J. E. Kuijpers.

Ethics declarations

Competing interests

J.W.H. is founder and co-owner at FlowChamber b.v. R.W.F. is founder of CambCol Laboratories Ltd. Other authors declare no relevant competing interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Figure 1.

Supplementary Figure 2.

Supplementary Figure 3.

Supplementary Figure 4.

Supplementary Information 1.

Supplementary Information 2.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

van Geffen, J.P., Swieringa, F., van Kuijk, K. et al. Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome. Sci Rep 10, 21407 (2020). https://doi.org/10.1038/s41598-020-78522-9

Download citation

Received: 11 September 2020
Accepted: 23 November 2020
Published: 08 December 2020
DOI: https://doi.org/10.1038/s41598-020-78522-9

This article is cited by

Nephrotic syndrome: pathophysiology and consequences
- Ponticelli Claudio
- Moroni Gabriella
Journal of Nephrology (2023)
Characteristics of cerebral ischemic stroke based on moyamoya disease and atherosclerosis-associated intracranial arterial stenosis
- Zhiying Chen
- Xiaoqin Wu
- Ran Meng
Neurological Sciences (2022)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.